Vilacto Bio (ZFLO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ZFLO Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Vilacto Bio's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2019)
(Mar 31 2019) (Dec 31 2018) (Sep 30 2018) (Jun 30 2018)
Assets
Cash & cash equivalent0.12
Cash & Short-term Investments0.00
Accounts receivable0.00
Loans and Leases Receivable, Related Parties2.03
Inventories0.12
Prepaid Expense, Current AS0.00
Total Current Assets2.28
Intangible Assets0.15
Total Assets0.40
Liabilities
Accounts Payable, Current AC0.05
Derivative Liability, Current DE0.35
Other Liabilities, Current2.52
Total Current Liabilities2.91
Long-term debt0.17
Total Long-term Debt0.17
Total Liabilities2.91
Stockholders' Equity
Shares Payable0.01
Common Stock Value1.91
Additional Paid In Capital Common Stock4.03
Retained Earnings / Accumulated Deficit-8.47
Other Equity0.00
Common Stockholder's Equity-2.51
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-2.51
Liabilities & Stockholder's Equity0.40
4 historic quarters locked

Sign in to unlock the full Vilacto Bio balance sheet history.

About ZFLO Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.